Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Other Issues:
Previous Next
  [Index by Author]
 
Contents: Volume 25, Issue 28
October 1, 2007
 

Down EDITORIALS
Down ORIGINAL REPORTS
  Down Thoracic Oncology
  Down Genitourinary Cancer
  Down Gastrointestinal Cancer
  Down Supportive Care and Quality of Life
  Down Breast Cancer
  Down Hematologic Malignancies
  Down Gynecologic Cancer
  Down Pediatric Oncology
Down REVIEW ARTICLE
Down DIAGNOSIS IN ONCOLOGY
Down ART OF ONCOLOGY
Down CORRESPONDENCE
Down ERRATA

Find articles in this issue containing these words:
[Search ALL Issues]


Table of Contents (PDF) | Editorial Board (PDF) | Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

 
EDITORIALS Back
Tumor mRNA Expression Profiles Predict Responses to Chemotherapy
John D. Minna, Luc Girard, and Yang Xie
JCO Oct 1 2007: 4329–4336. [Full Text] [PDF]  
Redefining the Refined Retroperitoneal Lymph Node Dissection in Testis Cancer: A SWOT Analysis of Nonrandomized Data
Marc B. Garnick
JCO Oct 1 2007: 4337–4338. [Full Text] [PDF]  
Adjuvant Management of Rectal Cancer: The More We Learn, the Less We Know
Bruce D. Minsky
JCO Oct 1 2007: 4339–4340. [Full Text] [PDF]  
The Graying of Testis Cancer Patients: What Have We Learned?
Dean F. Bajorin
JCO Oct 1 2007: 4341–4343. [Full Text] [PDF]  
Move Onward, Press Forward, and Take a Deep Breath: Can Lifestyle Interventions Improve the Quality of Life of Women With Breast Cancer, and How Can We Be Sure?
Wendy Demark-Wahnefried
JCO Oct 1 2007: 4344–4345. First published on Sep 4 2007; 10.1200/JCO.2007.13.1052. [Full Text] [PDF]  
Refining the Optimal Chemotherapy Regimen in Good Prognosis Germ Cell Cancer: Interpretation of the Current Body of Knowledge
Ronald de Wit
JCO Oct 1 2007: 4346–4349. [Full Text] [PDF]  
 
ORIGINAL REPORTS Back

Thoracic Oncology Back

Pharmacogenomic Strategies Provide a Rational Approach to the Treatment of Cisplatin-Resistant Patients With Advanced Cancer
  David S. Hsu, Bala S. Balakumaran, Chaitanya R. Acharya, Vanja Vlahovic, Kelli S. Walters, Katherine Garman, Carey Anders, Richard F. Riedel, Johnathan Lancaster, David Harpole, Holly K. Dressman, Joseph R. Nevins, Phillip G. Febbo, and Anil Potti
  JCO Oct 1 2007: 4350–4357. [Abstract] [Full Text] [PDF] [Chinese PDF] [Supplementary Data Tables]  
Global Histone Modifications Predict Prognosis of Resected Non–Small-Cell Lung Cancer
  Fabrice Barlési, Giuseppe Giaccone, Marielle I. Gallegos-Ruiz, Anderson Loundou, Simone W. Span, Pierre Lefesvre, Frank A.E. Kruyt, and Jose Antonio Rodriguez
  JCO Oct 1 2007: 4358–4364. [Abstract] [Full Text] [PDF]  

Genitourinary Cancer Back

Incidence of Metastatic Nonseminomatous Germ Cell Tumor Outside the Boundaries of a Modified Postchemotherapy Retroperitoneal Lymph Node Dissection
  Brett S. Carver, Bobby Shayegan, Scott Eggener, Jason Stasi, Robert J. Motzer, George J. Bosl, and Joel Sheinfeld
  JCO Oct 1 2007: 4365–4369. [Abstract] [Full Text] [PDF]  
Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer
  Alexandra W. van den Belt-Dusebout, Ronald de Wit, Jourik A. Gietema, Simon Horenblas, Marieke W.J. Louwman, Jacques G. Ribot, Harald J. Hoekstra, Gabey M. Ouwens, Berthe M.P. Aleman, and Flora E. van Leeuwen
  JCO Oct 1 2007: 4370–4378. [Abstract] [Full Text] [PDF]  

Gastrointestinal Cancer Back

Patients With Curative Resection of cT3-4 Rectal Cancer After Preoperative Radiotherapy or Radiochemotherapy: Does Anybody Benefit From Adjuvant Fluorouracil-Based Chemotherapy? A Trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group
  Laurence Collette, Jean-Francois Bosset, Marcel den Dulk, France Nguyen, Laurent Mineur, Philippe Maingon, Ljiljana Radosevic-Jelic, Marianne Piérart, and Gilles Calais
  JCO Oct 1 2007: 4379–4386. [Abstract] [Full Text] [PDF] [Chinese PDF]  

Supportive Care and Quality of Life Back

Randomized Controlled Trial of Yoga Among a Multiethnic Sample of Breast Cancer Patients: Effects on Quality of Life
  Alyson B. Moadel, Chirag Shah, Judith Wylie-Rosett, Melanie S. Harris, Sapana R. Patel, Charles B. Hall, and Joseph A. Sparano
  JCO Oct 1 2007: 4387–4395. First published on Sep 4 2007; 10.1200/JCO.2006.06.6027. [Abstract] [Full Text] [PDF]  
Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial
  Kerry S. Courneya, Roanne J. Segal, John R. Mackey, Karen Gelmon, Robert D. Reid, Christine M. Friedenreich, Aliya B. Ladha, Caroline Proulx, Jeffrey K.H. Vallance, Kirstin Lane, Yutaka Yasui, and Donald C. McKenzie
  JCO Oct 1 2007: 4396–4404. First published on Sep 4 2007; 10.1200/JCO.2006.08.2024. [Abstract] [Full Text] [PDF]  

Breast Cancer Back

Prognostic Significance of Overexpression and Phosphorylation of Epidermal Growth Factor Receptor (EGFR) and the Presence of Truncated EGFRvIII in Locoregionally Advanced Breast Cancer
  Yago Nieto, Fatima Nawaz, Roy B. Jones, Elizabeth J. Shpall, and Samia Nawaz
  JCO Oct 1 2007: 4405–4413. [Abstract] [Full Text] [PDF] [Polish PDF]  
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
  W. Fraser Symmans, Florentia Peintinger, Christos Hatzis, Radhika Rajan, Henry Kuerer, Vicente Valero, Lina Assad, Anna Poniecka, Bryan Hennessy, Marjorie Green, Aman U. Buzdar, S. Eva Singletary, Gabriel N. Hortobagyi, and Lajos Pusztai
  JCO Oct 1 2007: 4414–4422. First published on Sep 4 2007; 10.1200/JCO.2007.10.6823. [Abstract] [Full Text] [PDF]  
Human Epidermal Growth Factor Receptor 2 Status Correlates With Lymph Node Involvement in Patients With Estrogen Receptor (ER) –Negative, but With Grade in Those With ER-Positive Early-Stage Breast Cancer Suitable for Cytotoxic Chemotherapy
  John M.S. Bartlett, Ian O. Ellis, Mitch Dowsett, Elizabeth A. Mallon, David A. Cameron, Stephen Johnston, Emma Hall, Roger A'Hern, Clare Peckitt, Judith M. Bliss, Lindsay Johnson, Peter Barrett-Lee, and Paul Ellis
  JCO Oct 1 2007: 4423–4430. [Abstract] [Full Text] [PDF] [Chinese PDF]  
Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases
  Allan Lipton, Guenther G. Steger, Jazmin Figueroa, Cristina Alvarado, Philippe Solal-Celigny, Jean-Jacques Body, Richard de Boer, Rossana Berardi, Pere Gascon, Katia S. Tonkin, Robert Coleman, Alexander H.G. Paterson, Mark C. Peterson, Michelle Fan, Amy Kinsey, and Susie Jun
  JCO Oct 1 2007: 4431–4437. First published on Sep 4 2007; 10.1200/JCO.2007.11.8604. [Abstract] [Full Text] [PDF]  
Relationship Between Epidemiologic Risk Factors and Breast Cancer Recurrence
  Abenaa M. Brewster, Kim-Anh Do, Patricia A. Thompson, Karin M. Hahn, Aysegul A. Sahin, Yumei Cao, Maureen M. Stewart, James L. Murray, Gabriel N. Hortobagyi, and Melissa L. Bondy
  JCO Oct 1 2007: 4438–4444. First published on Sep 4 2007; 10.1200/JCO.2007.10.6815. [Abstract] [Full Text] [PDF]  

Hematologic Malignancies Back

Measurement of In Vivo BCR-ABL Kinase Inhibition to Monitor Imatinib-Induced Target Blockade and Predict Response in Chronic Myeloid Leukemia
  Deborah White, Verity Saunders, Andrew Grigg, Chris Arthur, Robin Filshie, Michael F. Leahy, Kevin Lynch, L. Bik To, and Timothy Hughes
  JCO Oct 1 2007: 4445–4451. [Abstract] [Full Text] [PDF]  
Phase II Pethema Trial of Alternating Bortezomib and Dexamethasone As Induction Regimen Before Autologous Stem-Cell Transplantation in Younger Patients With Multiple Myeloma: Efficacy and Clinical Implications of Tumor Response Kinetics
  Laura Rosiñol, Albert Oriol, Maria Victoria Mateos, Anna Sureda, Pedro García-Sánchez, Norma Gutiérrez, Adrián Alegre, Juan José Lahuerta, Javier de la Rubia, Carlos Herrero, Xiangyang Liu, Helgi Van de Velde, Jesús San Miguel, and Joan Bladé
  JCO Oct 1 2007: 4452–4458. First published on Sep 4 2007; 10.1200/JCO.2007.12.3323. [Abstract] [Full Text] [PDF]  
Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network
  Antonio Palumbo, Patrizia Falco, Paolo Corradini, Antonietta Falcone, Francesco Di Raimondo, Nicola Giuliani, Claudia Crippa, Giovannino Ciccone, Paola Omedè, Maria Teresa Ambrosini, Francesca Gay, Sara Bringhen, Pellegrino Musto, Robin Foà, Robert Knight, Jerome B. Zeldis, Mario Boccadoro, and Maria Teresa Petrucci
  JCO Oct 1 2007: 4459–4465. First published on Sep 4 2007; 10.1200/JCO.2007.12.3463. [Abstract] [Full Text] [PDF]  

Gynecologic Cancer Back

Phase III Randomized Trial of Intravenous Cisplatin Plus a 24- or 96-Hour Infusion of Paclitaxel in Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
  David R. Spriggs, Mark F. Brady, Luis Vaccarello, Daniel L. Clarke-Pearson, Robert A. Burger, Robert Mannel, John F. Boggess, Roger B. Lee, and Mark Hanly
  JCO Oct 1 2007: 4466–4471. [Abstract] [Full Text] [PDF]  

Pediatric Oncology Back

Place and Provision of Palliative Care for Children With Progressive Cancer: A Study by the Paediatric Oncology Nurses’ Forum/United Kingdom Children's Cancer Study Group Palliative Care Working Group
  Jan Vickers, Anne Thompson, Gary S. Collins, Margaret Childs, and Richard Hain
  JCO Oct 1 2007: 4472–4476. [Abstract] [Full Text] [PDF]  
 
REVIEW ARTICLE Back
Long-Term Health Status Among Survivors of Childhood Cancer: Does Sex Matter?
  Gregory T. Armstrong, Charles A. Sklar, Melissa M. Hudson, and Leslie L. Robison
  JCO Oct 1 2007: 4477–4489. [Abstract] [Full Text] [PDF]  
 
DIAGNOSIS IN ONCOLOGY Back
Anaplastic Large Cell Lymphoma in Leukemic Transformation: Successful Treatment by Transplantation
Shang-Ju Wu, Ming Yao, Hwei-Fang Tien, Jih-Luh Tang, Chung-Wu Lin, and Yao-Chang Chen
JCO Oct 1 2007: 4490–4492. [Full Text] [PDF]  
Long-Term Survival and Secondary Acute Leukemia After Fotemustine Therapy for Metastatic Melanoma
Saar Gill, Jeremy Shapiro, David Westerman, and H. Miles Prince
JCO Oct 1 2007: 4493–4494. [Full Text] [PDF]  
Enlarging Residual Mass After Treatment of a Nonseminomatous Germ Cell Tumor: Growing Teratoma Syndrome or Cancer Recurrence?
Nicolas Aide, François Comoz, and Emmanuel Sevin
JCO Oct 1 2007: 4494–4496. [Full Text] [PDF]  
 
ART OF ONCOLOGY Back
When Opioids Cause Pain
Mellar P. Davis, Lauren A. Shaiova, and Martin S. Angst
JCO Oct 1 2007: 4497–4498. [Full Text] [PDF]  
 
CORRESPONDENCE Back
Role of Forkhead Box Protein 3 Expression in Invasive Breast Cancer
Anna M. Wolf, Holger Rumpold, Dominik Wolf, Guenther Gastl, Daniel Reimer, Nina Jenewein, Christian Marth, and Alain G. Zeimet
JCO Oct 1 2007: 4499–4500. [Full Text] [PDF]  
In Reply
Gaynor J. Bates, Paola A. Bignone, and Alison H. Banham
JCO Oct 1 2007: 4500–4501. [Full Text] [PDF]  
Age Group–Specific Gap Between Treatment Cost of and Mortality Due to Breast and Colorectal Cancer
Imre Boncz, Andor Sebestyén, István Pintér, József Betlehem, Ildikó Kriszbacher, Tibor Csere, László Mangel, and József Bódis
JCO Oct 1 2007: 4501–4502. [Full Text] [PDF]  
In Reply
Hanna Sanoff, Harry Bleiberg, and Richard Goldberg
JCO Oct 1 2007: 4502–4503. [Full Text] [PDF]  
Regarding Adjuvant Radiation Therapy in Merkel Cell Carcinoma: Selection Bias and Its Affect on Overall Survival
Douglas M. Housman, Roy H. Decker, and Lynn D. Wilson
JCO Oct 1 2007: 4503–4504. [Full Text] [PDF]  
In Reply
Pablo Mojica, David Smith, and Joshua D.I. Ellenhorn
JCO Oct 1 2007: 4504–4505. [Full Text] [PDF]  
Barriers to Effective TRAIL-Targeted Therapy of Malignancy
Martin J.S. Dyer, Marion MacFarlane, and Gerald M. Cohen
JCO Oct 1 2007: 4505–4506. [Full Text] [PDF]  
Does a Statistically Significant Survival Benefit of Erlotinib Plus Gemcitabine for Advanced Pancreatic Cancer Translate Into Clinical Significance and Value?
Rebecca A. Miksad, Lowell Schnipper, and Michael Goldstein
JCO Oct 1 2007: 4506–4507. [Full Text] [PDF]  
In Reply
Malcolm J. Moore, Heather Jane Au, and Wendy Parulekar
JCO Oct 1 2007: 4508. [Full Text] [PDF]  
Intra-CSF Rituximab for Lymhomatous Meningitis
Marc C. Chamberlain and Michael J. Glantz
JCO Oct 1 2007: 4508–4509. [Full Text] [PDF]  
In Reply
James Rubenstein, Lauren Abrey, Ranjana Advani, Marc Shuman, Tony Tsai, and Joan O'Brien
JCO Oct 1 2007: 4509–4511. [Full Text] [PDF]  
 
ERRATA Back
ERRATUM
JCO Oct 1 2007: 4512. [Full Text] [PDF]  
ERRATUM
JCO Oct 1 2007: 4512. [Full Text] [PDF]  


To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online